Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001737287-25-000036
Filing Date
2025-03-13
Accepted
2025-03-13 16:04:47
Documents
109
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K allo-20241231.htm   iXBRL 10-K 2146781
2 EX-10.13 allo-20241231xex1013.htm EX-10.13 1217339
3 EX-19.1 allo-20241231xex191.htm EX-19.1 32716
4 EX-23.1 allo-20241231xex231.htm EX-23.1 3880
5 EX-31.1 allo-20241231xex311.htm EX-31.1 10822
6 EX-31.2 allo-20241231xex312.htm EX-31.2 10331
7 EX-32.1 allo-20241231xex321.htm EX-32.1 5871
8 EX-32.2 allo-20241231xex322.htm EX-32.2 5654
14 allo-20241231_g1.jpg GRAPHIC 163882
15 allo-20241231_g2.jpg GRAPHIC 85980
16 allo-20241231_g3.jpg GRAPHIC 120872
17 allo-20241231_g4.jpg GRAPHIC 25109
18 allo-20241231_g5.jpg GRAPHIC 28959
19 allo-20241231_g6.jpg GRAPHIC 28417
20 allo-20241231_g7.jpg GRAPHIC 132356
  Complete submission text file 0001737287-25-000036.txt   13492617

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allo-20241231.xsd EX-101.SCH 86032
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT allo-20241231_cal.xml EX-101.CAL 88862
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT allo-20241231_def.xml EX-101.DEF 488015
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allo-20241231_lab.xml EX-101.LAB 939547
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allo-20241231_pre.xml EX-101.PRE 730768
112 EXTRACTED XBRL INSTANCE DOCUMENT allo-20241231_htm.xml XML 1199298
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38693 | Film No.: 25735689
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)